Literature DB >> 1267424

Trimethoprim-sulfamethoxazole in murine toxoplasmosis.

J S Remington.   

Abstract

The combination trimethoprim-sulfamethoxazole had no greater activity in a murine model of toxoplasmosis than did sulfamethoxazole alone.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1267424      PMCID： PMC429507          DOI： 10.1128/AAC.9.2.222

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole.

Authors:  R Norrby; T Eilard; A Svedhem; E Lycke
Journal:  Scand J Infect Dis       Date:  1975

2.  [Acquired toxoplasmosis: a new chemotherapy: the sulfamethoxazole-trimethoprim combination].

Authors:  A Domart; M Robineau; C Carbon
Journal:  Nouv Presse Med       Date:  1973-02-03

3.  Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

4.  The effect of trimethoprim on acute experimental toxoplasmosis in mice.

Authors:  J Sander; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

5.  Effect of clindamycin on acute and chronic toxoplasmosis in mice.

Authors:  F G Araujo; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191
  5 in total
  4 in total

1.  Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.

Authors:  J Chan; B J Luft
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; C K Kim; J M Foy; M J Linke; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

4.  Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis.

Authors:  Amal FarahatAllam; Amel Youssef Shehab; Nerrmine Mogahed Fawzy Hussein Mogahed; Hoda Fahmy Farag; Yasmen Elsayed; Naglaa Fathi Abd El-Latif
Journal:  Heliyon       Date:  2020-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.